Veer Bhavnagri - 18 May 2021 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
General Counsel
Signature
Veer Bhavnagri
Issuer symbol
ALLO
Transactions as of
18 May 2021
Transactions value $
-$138,650
Form type
4
Filing time
20 May 2021, 17:19:43 UTC
Previous filing
17 May 2021
Next filing
16 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Options Exercise $11.4K +5K +1.19% $2.27 426K 18 May 2021 Direct
transaction ALLO Common Stock Sale -$150K -5K -1.17% $30.00* 421K 18 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to Buy) Options Exercise $0 -5K -3.64% $0.00 132K 18 May 2021 Common Stock 5K $2.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020.
F2 25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.